VirtualScopics to Present at the Upcoming Rodman & Renshaw Annual Global Investment Conference
ROCHESTER, N.Y., Sept. 4, 2012 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging solutions, announced today that Ms. Molly Henderson, the company's chief business and financial officer, will be presenting a corporate overview at the Rodman & Renshaw Healthcare Conference being held from September 9 – 11, 2012 at the Waldorf Astoria in New York City. Ms. Henderson's presentation will be on Tuesday, September 11, 2012 at 2:00pm ET.
A live webcast of the company's presentation will be available for 30 days in the Investor Relations section of the company's website, www.virtualscopics.com.About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit www.virtualscopics.com.
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby. These forward-looking statements include, but are not limited to, statements regarding the expected benefits of the Company's investment in infrastructure and new customer contract signings and awards and/or statement